Related Experiment Video

Updated: Jul 20, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Hyperglycemia and outcome after myocardial infarction and cardiac surgery: so what?

Michael J Hiesmayr1

  • 1Department of Cardiac-Thoracic-Vascular Anaesthesia & Intensive Care Medicine, Medical University Vienna, Vienna, Austria. michael.hiesmayr@meduniwien.ac.at

Seminars in Cardiothoracic and Vascular Anesthesia
|September 9, 2006
PubMed

Insights

Stress-induced hyperglycemia, common in acute illness like heart attack and surgery, significantly increases mortality risk, especially in non-diabetics. Controlling blood glucose levels offers clear clinical benefits, particularly for non-diabetic patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Hyperglycemia frequently occurs during acute medical events such as myocardial infarction and major surgery.
  • Up to 100% of cardiac surgery patients experience hyperglycemia, termed stress-induced hyperglycemia.
  • This condition negatively impacts patient outcomes and increases mortality risk, particularly in non-diabetic individuals.

Purpose of the Study:

  • To investigate the impact of stress-induced hyperglycemia on patient outcomes after myocardial infarction and cardiac surgery.
  • To evaluate the clinical benefits of controlling hyperglycemia in these patient populations.
  • To determine optimal glycemic targets for improved patient outcomes.

Main Methods:

  • Observational analysis of patients experiencing hyperglycemia during acute illness and post-cardiac surgery.
  • Comparative analysis of outcomes between patients with controlled versus uncontrolled hyperglycemia.
  • Literature review to synthesize current evidence on glycemic control targets.

Main Results:

  • Stress-induced hyperglycemia is associated with a fourfold increase in mortality, notably in non-diabetic patients.
  • Glycemic control demonstrates significant clinical benefits, most pronounced in non-diabetic patients.
  • Optimal blood glucose normalization targets are likely between 80 and 125 mg/dL, though further research is ongoing.

Conclusions:

  • Stress-induced hyperglycemia is a critical factor adversely affecting outcomes in myocardial infarction and cardiac surgery.
  • Intensive glucose control in hyperglycemic patients, especially non-diabetics, leads to improved clinical results.
  • Targeting blood glucose levels between 80-125 mg/dL may represent an optimal strategy for managing hyperglycemia in acute illness.

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...